Life Sciences
Canada Guide 2025 : Nationwide - Canada
Band 3
Contact number
+1 416 862 7525About
Provided by Gowling WLG (Canada) LLP
With over 150 professionals around the world, Gowling WLG’s Life Sciences Group has the technical expertise required to understand the unique challenges you face throughout your life cycle.
We work with your business, intellectual property, human resource and regulatory teams to provide guidance and support in key areas of life sciences – from patent protection, clinical trial protocols and agreements and drug submissions to licensing, financing, employment, research and development, pricing and more.
Fully immersed in the sector, many of us have life sciences-related degrees and have spent time in our careers as scientists. This means we have the hands-on experience required to truly understand your operating environment, commercial needs and challenges.
The areas we cover include:
- Clinical trials and drug manufacturing agreements
- Drug pricing and reimbursement
- Freedom to operate opinions
- Labelling, advertising and distribution
- Licensing, development and commercialisation agreements
- Joint ventures
- Patent and brand protection and litigation
- Risk management, product liability and litigation
- Pharmaceutical services and healthcare
- Regulatory law
- Acquisitions, mergers spin-outs and disposals, fund structures and initial public offerings (IPOs)
- Tax
- Competition and antitrust
- Government relations
Chambers Review
With internationally renowned IP expertise, Gowling WLG is highlighted for its skilful handling of patent prosecution and litigation for a broad range of clients in the life sciences space. The law firm is a particularly popular choice for major multinational pharmaceutical and biotechnology companies. Other clients include manufacturers and research organisations. The team also advises on acquisitions and financings, as well as a wide range of regulatory issues, including pricing, marketing and distribution of products.
Marc Richard heads the firm's life sciences department in Canada and is a key contact.
Work Highlights
- Gowling WLG advised NurExone on a private placement financinginvolving the issuance of 7,091,993 units of the company for gross proceeds of almost CAD2 million.
Strengths
Provided by Chambers
"Gowling WLG has experts for different topics and are immediately available and responsive."
"The firm has got a very deep patent prosecution practice."
"Gowling WLG has experts for different topics and are immediately available and responsive."
"The firm has got a very deep patent prosecution practice."
Members
Provided by Gowling WLG (Canada) LLP
John Norman
Head of Department